Generic Exforge market getting heated

Starting in October, CJ Pharmaceutical Unit will gear up to enter the domestic combination-form hypertensive drug market with a tool of its incrementally modified drug Exone (valsartan and amlodipine adipate) in a bid to challenge Novartis’s Exforge (valsartan and amlodipine besylate).

This once-a-day oral prescription drug is known to be most effective in patients whose blood pressure is no...